XML 77 R52.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Restricted Net Assets and Parent Company Only Condensed Financial Information (Tables)
 12 Months Ended
Jun. 30, 2024
Restricted Net Assets and Parent Company Only Condensed Financial Information [Abstract]  
Schedule of Condensed Balance Sheets Condensed balance sheets
   As of June 30, 
   2023   2024   2024 
   RMB   RMB   US$ 
             
ASSETS            
Current assets:            
Cash and cash equivalents   23,469    64,689    8,902 
Short-term investments   116,090    -    - 
Amounts due from intra-Group companies   121,685    62,153    8,553 
Prepayments and other current assets   4,798    75,760    10,424 
Total current assets   266,042    202,602    27,879 
Investment in subsidiaries   183,216    453,384    62,388 
Total non-current assets   183,216    453,384    62,388 
TOTAL ASSETS   449,258    655,986    90,267 
Accrued expenses and other current liabilities   250    300    41 
Amounts due to intra-Group companies   
-
    3,478    479 
Total current liabilities   250    3,778    520 
Net liabilities of the VIEs   225,310    135,724    18,676 
Total non-current liabilities   225,310    135,724    18,676 
TOTAL LIABILITIES   225,560    139,502    19,196 
SHAREHOLDERS’ EQUITY               
Class A ordinary shares   78    81    11 
Class B ordinary shares   34    34    5 
Treasury stock   
-
    (109,257)   (15,034)
Additional paid-in capital   1,171,092    1,192,474    164,090 
Accumulated other comprehensive income   22,182    17,313    2,382 
Accumulative deficit   (969,688)   (584,161)   (80,383)
TOTAL SHAREHOLDERS’ EQUITY   223,698    516,484    71,071 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   449,258    655,986    90,267 

 
Schedule of Condensed Statements of Operations and Comprehensive Loss Condensed statements of operations and comprehensive (loss)/income
   For the years ended June 30, 
   2022   2023   2024   2024 
   RMB   RMB   RMB   US$ 
                 
Revenues   
-
    
-
    
-
    
-
 
Cost of revenues   (27,583)   (26,486)   (13,651)   (1,878)
Gross Profit   (27,583)   (26,486)   (13,651)   (1,878)
Operating expenses:                    
Sales and marketing expenses   (86,682)   (52,182)   2,653    365 
Research and development expenses   (120,558)   (49,047)   (1,887)   (260)
General and administrative expenses   (57,287)   (72,164)   (28,706)   (3,950)
Total operating expenses   (264,527)   (173,393)   (27,940)   (3,845)
Loss from operations   (292,110)   (199,879)   (41,591)   (5,723)
Other (loss)/income:                    
Interest income   
-
    74    2,020    278 
Others, net   
-
    680    6,841    941 
Share of (loss)/income from subsidiaries   (4,028)   105,565    348,484    47,953 
Income/(loss) from the VIEs   62,712    (14,977)   69,773    9,601 
(Loss)/Income before income tax   (233,426)   (108,537)   385,527    53,050 
Income tax expense   
-
    
-
    
-
    
-
 
Net (loss)/income   (233,426)   (108,537)   385,527    53,050 
Allocation of accretion of Predecessors’ preferred shares   (22,655)   
-
    
-
    
-
 
Accretion of the Company’s preferred shares   (2,987)   (22,379)   
-
    
-
 
Net (loss)/income attributable to ordinary shareholders of QuantaSing Group Limited   (259,068)   (130,916)   385,527    53,050 
                     
Net (loss)/income   (233,426)   (108,537)   385,527    53,050 
Other comprehensive income/(loss)                    
Foreign currency translation adjustments, net of nil tax   1,839    20,343    (4,869)   (670)
Total other comprehensive income/(loss)   1,839    20,343    (4,869)   (670)
Total comprehensive (loss)/income   (231,587)   (88,194)   380,658    52,380 

 
Schedule of Condensed Statements of Cash Flows Condensed statements of cash flows
   For the years ended June 30, 
   2022   2023   2024   2024 
   RMB   RMB   RMB   US$ 
                 
Net cash used in operating activities   (49)   (13,082)   (8,427)   (1,160)
                     
Cash flows from investing activities:                    
Loan provided to subsidiaries   (127,165)   (215,277)   (117,217)   (16,130)
Loan repaid by subsidiaries   80,049    100,937    235,424    32,395 
Purchase of short-term investments   
-
    (145,652)   
-
    
-
 
Proceeds from short-term investments   
-
    36,300    59,520    8,190 
Net cash (used in)/provided by investing activities   (47,116)   (223,692)   177,727    24,455 
                     
Cash flows from financing activities:                    
Contribution from Predecessors   76,178    
-
    
-
    
-
 
Proceeds from loans from Predecessors   50,986    
-
    
-
    
-
 
Repayment of loans to Predecessors   (79,981)   
-
    
-
    
-
 
Proceeds from exercise of share options   
-
    
-
    2,467    339 
Repurchase of ADSs   
-
    
-
    (130,409)   (17,945)
Proceeds from issuance of Class A ordinary shares upon the completion of IPO (net of issuance costs paid)   
-
    256,764    
-
    
-
 
Net cash provided by/(used in) financing activities   47,183    256,764    (127,942)   (17,606)
Effect of exchange rate changes on cash and cash equivalents   
-
    3,461    (138)   (16)
Net increase in cash and cash equivalents   18    23,451    41,220    5,673 
Cash and cash equivalents at beginning of the year   
-
    18    23,469    3,229 
Cash and cash equivalents at end of the year   18    23,469    64,689    8,902